Global pharmaceutical and healthcare company, focusing on pharmaceuticals, vaccines, and consumer healthcare products.
GSK plc, a global leader in healthcare, specializes in the research, development, and commercialization of pharmaceuticals, vaccines, and consumer health products worldwide. Headquartered in Brentford, UK, the company operates through four key segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. Its extensive portfolio includes therapeutic medicines addressing respiratory, HIV, oncology, cardiovascular, and dermatology conditions, among others. Additionally, GSK offers a broad range of consumer healthcare products spanning wellness, oral health, nutrition, and skin health categories. These products encompass various forms such as tablets, syrups, nasal sprays, and trans-dermal patches.
Founded in 1715, GSK plc has evolved into a cornerstone of the healthcare industry, leveraging over three centuries of expertise in advancing medical innovation. The company's strategic collaborations with industry leaders like Novartis, Sanofi SA, and CureVac AG reinforce its commitment to pioneering new treatments and vaccines. GSK's partnerships extend to cutting-edge biotechnological ventures, enhancing its capabilities in immunotherapy and diagnostic advancements.
Under its former name GlaxoSmithKline plc, the company rebranded as GSK plc in May 2022, reflecting its dynamic evolution and continued dedication to shaping the future of global healthcare. With a steadfast commitment to improving human health, GSK remains at the forefront of innovation, driving transformative solutions that address the evolving needs of patients worldwide